Produkty 165195-35-7

CAS 165195-35-7 występuje w naszej ofercie pod nazwami: 4-Androsten-17alpha-ol-3-one-2,2,4,6,6-d5, 98 atom % D, min 96% Chemical Purity, 4-Androsten-17α-ol-3-one-2,2,4,6,6-d5. Oferty producentów: CDN, Biosynth. Dostępne opakowania: 0,01g, 0,005g, 50mg, 25mg.

4-Androsten-17alpha-ol-3-one-2,2,4,6,6-d5, 98 atom % D, min 96% Chemical Purity
CDN
  • opakowanie: 0,01g, 0,005g
  • Warianty: 2
Zobacz produkt
4-Androsten-17α-ol-3-one-2,2,4,6,6-d5
Biosynth
  • opakowanie: 50mg, 25mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8R,9S,10R,13S,14S,17R)-2,2,4,6,6-pentadeuterio-17-hydroxy-10,13-dimethyl-1,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one (CAS 165195-35-7) to związek chemiczny o wzorze sumarycznym C19H28O2 i masie molowej 293.5 g/mol. Nazwa systematyczna IUPAC: (8R,9S,10R,13S,14S,17R)-2,2,4,6,6-pentadeuterio-17-hydroxy-10,13-dimethyl-1,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one. InChIKey: MUMGGOZAMZWBJJ-PPXDMADMSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O2
Masa molowa293.5 g/mol
Nazwa IUPAC(8R,9S,10R,13S,14S,17R)-2,2,4,6,6-pentadeuterio-17-hydroxy-10,13-dimethyl-1,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
InChIKeyMUMGGOZAMZWBJJ-PPXDMADMSA-N
SMILES[2H]C1=C2[C@](CC(C1=O)([2H])[2H])([C@H]3CC[C@]4([C@H]([C@@H]3CC2([2H])[2H])CC[C@H]4O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 4-Androsten-17?-ol-3-one-2,2,4,6,6-d5, orb2300088, Epitestosterone-d5 Solution in Acetonitrile, 100ug/mL
Powiązane formy tego związku
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O2
(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O2
(8R,9S,10R,13S,14S,17S)-16,16,17-trideuterio-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-one C19H28O2
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O2
(8R,9S,10R,13S,14S,17S)-2,2,4,6,6-pentadeuterio-17-hydroxy-10,13-dimethyl-1,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C19H28O2
(8R,9S,10R,13S,14S,17R)-16,16,17-trideuterio-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-one C19H28O2
(8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-10-(trideuteriomethyl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O2
(8R,9S,10R,13S,14S,17S)-1,2-dideuterio-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O2
Izomery (ten sam wzór sumaryczny)
(3S,5S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H28O2
(4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenoic acid C19H28O2
(3R,5R,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2